![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Celadon Pharmaceuticals Plc | LSE:CEL | London | Ordinary Share | GB00BDQYGP38 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
1.50 | 2.52% | 61.00 | 57.00 | 65.00 | 61.00 | 59.50 | 59.50 | 12,246 | 14:00:11 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Investment Advice | 149k | -7.14M | -0.1082 | -5.64 | 39.26M |
TIDMCEL
RNS Number : 8283G
Caparo Energy Ltd
18 May 2011
18 May 2011
Caparo Energy Ltd
("Caparo" or the "Company")
Directors Dealings
The Company has received notification that Raigersfield Capital Limited, a company wholly owned by Mr. Philip Swatman, a Non-executive Director of the Company, and members of his family, yesterday acquired 10,000 ordinary shares of no par value in the Company ("Ordinary Shares") at a price of 98.5 per Ordinary Share. Following this acquisition, Mr. Swatman now has a beneficial interest in 10,000 Ordinary Shares representing 0.006 per cent. of the total issued share capital of the Company.
For further information please contact:
Caparo Energy Limited Ravi Kailas, Chief Executive Officer +91 40 4396 0000 Strand Hanson Limited Angela Peace / Paul Cocker / James Harris +44 (0) 20 7409 3494 Mirabaud Securities LLP Peter Krens / Rory Scott +44 (0) 20 7878 3360 Pelham Bell Pottinger Charles Vivian / Philippe Polman +44 (0) 20 7861 3232
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDSSFAFSAFFSESI
1 Year Celadon Pharmaceuticals Chart |
1 Month Celadon Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions